Rossari Biotech Ltd Q2 FY2025 Concall Summary

Source transcript PDF: https://assets.stockscans.in/docs/udsvbv8blnyck2nl5kovaogw.pdf

Key Takeaways


The Export Pivot: Why Domestic Looks Soft

Edward Menezes: "It is a very conscious decision to push our products more in export. The same products would have been also pushed in the local or domestic market, but I believe that we would have got lower gains."

Textile: Volume Growth, Revenue Decline

Edward Menezes: "Sanjesh, on the domestic front in Textiles, we have not lost any market share. In fact, YoY volumes grew, like Ketan sir just now reported, that YoY volumes grew by 6%-7%."

HPPC & Institutional Cleaning: The Growth Engine


Animal Health & Nutrition: Strategy Reset

Edward Menezes: "In the previous years, we had focused a bit on the feed component itself, not only on the additives but also on the feed components, but we found that this strategy was not working out well for us because we were taking a hit on the margins. We dropped that strategy of going in for selling the feed part of it."

Margins: Gross Profit Up, EBITDA Flat

Ketan Sablok: "My only submission is that in the current year and maybe half of next year, what we see is we need to start full utilization of our capacities, all the new products, the new initiatives that we are taking, that is the key for us to kind of meet and within that goal, the targets for the EBITDA are, if we are at the level that we have done in the first half, around that number plus minus a few basis points, I think we would be happy with that."

Capacity Expansion & CAPEX


Guidance & Commitments

CommitmentSpecificsTimeline
Full-year revenue growth12%-13% top line growthFY25
Full-year EBITDA marginMaintain around 13.2%-13.5%FY25 and maybe H1 FY26
Loop reactors operationalEthoxylation capacity constraint removedEnd November / early December 2024
Reliance EO supply increaseAdditional volumes to feed loop reactorsStarting Q4 FY25
Bangladesh textile recoveryOrders and banking lines normalizeNext 1-2 months; business back toward end of Q3
Bangladesh receivables improvementPayment cycle normalizesBy March 2025
Institutional cleaning revenue₹250 croreFY25
CAPEX commissioningDahej and Unitop projects phased commissioningQ3, Q4 FY25 and Q1 FY26
Asset turns on new projects3 to 4xOn commissioning
Textile segment recoveryRecovery in textile businessNext calendar year
AHN second-half strengthHealthy growth; Q3 at 1.5x normal sales vs Q1/Q2H2 FY25

Key Metrics

MetricQ2 FY25
Revenue₹498.4 cr, +3% YoY
HPPC division revenue₹390 cr, +6% YoY from ₹367 cr
Textile Specialty Chemicals revenue₹84 cr, down from ₹96 cr YoY
Animal Health & Nutrition revenue₹24 cr, up from ₹20 cr YoY
Exports revenue₹130 cr, +21% YoY; exports now ~25% of overall sales
Gross margin+253 bps YoY, driven by product mix and operational optimization
EBITDA₹65.9 cr, +3.6% YoY from ₹63.6 cr
EBITDA margin13.2%, stable YoY
PAT₹35.3 cr, +7.3% YoY from ₹32.9 cr
H1 FY25 revenue growth~11% YoY
Full-year FY25 revenue growth guidance12%-13% YoY
Full-year FY25 EBITDA margin guidance13.2%-13.5%
Institutional cleaning revenue₹70-₹73 cr; H1 FY25 ~₹130 cr; FY25 guidance ₹250 cr
Textile domestic volume growth6-7% YoY
AHN specialty additives growth20% YoY
CAPEX spent so far₹60-₹65 cr; similar amount to be spent over next 6 months; total project budget enhanced to up to ₹146.25 cr
Expected asset turnover on new capacities3x-4x